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Abstract
Introduction
The ST-4821 complex (cc4821) is a leading cause of serogroup C and serogroup B invasive
meningococcal disease in China where diverse strains in two phylogenetic groups (groups 1
and 2) have acquired fluoroquinolone resistance. cc4821 was recently prevalent among car-
riage isolates in men who have sex with men in New York City (USA). Genome-level popula-
tion studies have thus far been limited to Chinese isolates. The aim of the present study was
to build upon these with an extended panel of international cc4821 isolates.
Methods
Genomes of isolates from Asia (1972 to 2017), Europe (2011 to 2018), North America
(2007), and South America (2014) were sequenced or obtained from the PubMLST Neis-
seria database. Core genome comparisons were performed in PubMLST.
Results
Four lineages were identified. Western isolates formed a distinct, mainly serogroup B subli-
neage with alleles associated with fluoroquinolone susceptibility (MIC <0.03 mg/L) and
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González-López JJ, et al. (2020) Genomic analysis
of the meningococcal ST-4821 complex–Western
clade, potential sexual transmission and predicted
antibiotic susceptibility and vaccine coverage.
PLoS ONE 15(12): e0243426. https://doi.org/
10.1371/journal.pone.0243426
Editor: William M. Shafer, Emory University School
of Medicine, UNITED STATES
Received: October 8, 2020
Accepted: November 23, 2020
Published: December 10, 2020
Copyright: © 2020 Lucidarme et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All draft genomes are
available from the https://pubmlst.org/organisms/
neisseria-spp database (accession number(s) are
listed in the S1 Table).
Funding: This work was supported by grants (ZS)
from the National Key Program for Infectious
Disease of China (contract no. 2013ZX10004221
and 2018ZX10714002-001). The funders had no
role in study design, data collection and analysis,
reduced penicillin susceptibility (MIC 0.094 to 1 mg/L). A third of these were from anogenital
sites in men who have sex with men and had unique denitrification gene alleles. Generally
4CMenB vaccine strain coverage was reliant on strain-specific NHBA peptides.
Discussion
The previously identified cc4821 group 2 was resolved into three separate lineages. Cluster-
ing of western isolates was surprising given the overall diversity of cc4821. Possible associ-
ation of this cluster with the anogenital niche is worthy of monitoring given concerns
surrounding antibiotic resistance and potential subcapsular vaccine escape.
Introduction
Neisseria meningitidis, the meningococcus, is a leading cause of meningitis and sepsis. Six ser-
ogroups (A, B, C, W, X and Y) cause the majority of invasive meningococcal disease (IMD)
globally. Prior to 2003/4, meningococcal serogroup A (MenA) was the most common cause of
IMD in China with periodic epidemics [1]. In 1982 the country introduced MenA polysaccha-
ride vaccination after which IMD stabilised at 0.2 to 1.0 per 100,000 [2].
In 2003/4 and 2004/5, a number of serogroup C (MenC) outbreaks occurred in Anhui
province due to a novel strain—the Sequence Type (ST)-4821 complex (cc4821) [2]. A national
survey of case, case-contact, and carrier isolates in 2004/5 revealed the existence of MenC
cc4821 in disease and/or carriage in 11 other provinces [2]. Subsequent analysis of geo-tempo-
rally diverse Chinese MenC isolates identified several cc4821 case and carrier isolates dating
back as far as 1978 [3]. In 2005 the serogroup A polysaccharide vaccine was replaced with a
MenA and MenC polysaccharide vaccine [4]. In recent years MenC cc4821 has become a lead-
ing and widespread cause of IMD in China. cc4821 has also emerged as a leading cause of ser-
ogroup B (MenB) disease which has tended to be more sporadic in nature [4]. cc4821 isolates
express diverse PorA subtypes, however, the majority of the MenC cases, particularly those
associated with the outbreaks, possessed PorA P1.7–2,14 [4].
High-resolution phylogenetic analyses of small numbers (n = 22 to 32) of Chinese cc4821
case and carrier isolates have found that cc4821 comprises two distinct groups—group 1 (or
group I) and group 2 (or group II) [5, 6]. The group 1 isolates were very closely related to one-
another and included a subcluster of isolates with PorA P1.7–2,14 (the epidemic clone [6]).
The group 2 isolates were relatively diverse and had a lower proportion of invasive isolates. In
the study by Guo et al. (2018) [6] the most common DNA gyrase subunit A (gyrA) allele
among the group 2 isolates, as well as the majority (22/29) of a distinct panel of group 2 isolates
from Shanghai, was a wild type allele, allele 12, which is associated with susceptibility (MIC
�0.03 mg/L; EUCAST v10.0) to ciprofloxacin among 137/138 PubMLST Neisseria isolates
(accessed 10th September 2020). Ciprofloxacin is commonly used for prophylaxis against IMD.
The remaining group 2 isolates possessed a variety of gyrA alleles with resistance-associated
mutations (MICS >0.03 mg/L; EUCAST v10.0) that affect amino acid residue 91 [7]. All of the
group 1 isolates possessed gyrA allele 71, containing the resistance-associated mutation T91I.
Concerns about antibiotic resistance are confounded by the existence of multiple MenB
strains in both groups 1 and 2 [5, 6] as a result of multiple capsular switch events [6]. No
MenB vaccine is currently licensed in China. Two subcapsular vaccines that are licensed else-
where afford strain coverage dependant on the presence and expression of cross-reactive pep-
tide variants among the prevailing meningococcal population [8, 9]. The 4CMenB vaccine
potentially covers isolates sufficiently expressing PorA P1.4, and/or a sufficiently cross-reactive
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factor H-binding protein (fHbp) variant 1 peptide, and/or a Neisseria adhesin A (NadA) vari-
ant NadA-1 or NadA-2/3 peptide, and/or a cross-reactive neisserial heparin–binding antigen
(NHBA) peptide. Coverage by MenB-fHbp is dependent on sufficient expression of fHbp.
Potential coverage of individual isolates is determined using the ELISA-based Meningococcal
Antigen Typing System (MATS; 4CMenB) [10] or the flow-cytometry based Meningococcal
Antigen Surface Expression (MeASurE; MenB-fHbp) [11] assays. A genetic version of MATS
(gMATS) has also been developed based on a large international MATS dataset [12]. The
emergence of a serogroup W cc4821 strain in both carriage and disease is also a cause for con-
cern [13], although highly effective serogroup W conjugate vaccines are available.
Although invasive disease due to cc4821 is rare outside of Asia, Guo et al. (2018) previously
noted the expansion of non-Chinese cc4821 isolates within the PubMLST Neisseria database
[6]. In a recent meningococcal carriage study in 706 men who have sex with men (MSM) in
New York City (USA), cc4821 was the most prevalent clonal complex identified accounting
for 14.3% (24/168) isolates [14]. Members of another strain, ST-11 complex lineage 11.2, have
caused multiple outbreaks of IMD in MSM in Europe and the USA and a large multistate out-
break of urethritis among predominantly heterosexual men in the USA [15]. The latter strain
(US_NmUC) has recently been detected in proctitis in MSM in the United Kingdom [16]. The
strains responsible have shown several adaptations to the anogenital niche including the acqui-
sition of active/efficient denitrification genes (aniA and norB) to enable growth in an anaero-
bic environment [17, 18]. A recent study in gonococci found an association between loss of
function (LOF) mutation in the efflux pump component, MtrC, and cervical infection. This
extended to US_NmUC in which 8.7% of isolates possessed LOF mutations versus 0.62% in a
large invasive disease collection [19].
In the present study, we expanded upon earlier work by sequencing additional Chinese
genomes and performing high resolution phylogenetic analyses on these and an extended
panel of all cc4821 genomes from multiple countries on several continents that are currently
available on the PubMLST Neisseria database (accessed 12th September 2019). We also charted
the distribution of ciprofloxacin resistance-associated gyrA mutations and penA mutations
associated with reduced susceptibility to penicillin; the nitrite reductase gene aniA; and poten-
tial cc4821 strain coverage by subcapsular (MenB) vaccines. Predicted functionality of MtrC
was assessed in a set of anogenital isolates.
Methods
Genome sequencing and database searches
New genome sequences were obtained for 138 Chinese cc4821 isolates collected between 1978
to 2017, inclusive (S1 Table). DNA was extracted from overnight cultures using the Wizard
genomic DNA purification kit (Promega, WI, USA) according to the manufacturer’s instruc-
tions. Paired end libraries were generated with average insert lengths of 350 bp or 500 bp.
Sequencing was performed on Illumina HiSeq 2000, 2500 or 4000 platforms (Illumina, CA,
USA).Genome assembly was performed using SOAPdenovo (release 1.04; http://soap.
genomics.org.cn/soapdenovo.html).
Other cc4821 genomes were obtained from the PubMLST Neisseria isolate database
(https://pubmlst.org/neisseria/) using the ‘search or browse database’ function (accessed 12/
09/2019). Isolates with>4 ST-4821 alleles among clonal complex-unassigned isolates (incom-
plete MLST profiles or unassigned STs) were also included.
Associated metadata and genotypic data were exported using the ‘export dataset’ function.
Stated capsular groups are from the ‘capsule_group’ field which is determined automatically
from the contents of the serogroup and/or genogroup fields in PubMLST.
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Phylogenetic analyses and identification of putative recombination events
Genomes were compared using the PubMLST genome comparator tool [20] in conjunction
with the meningococcal core genome MLST scheme (N. meningitidis cgMLST v1.0) [21] using
an ST-41/44 complex genome (PubMLST ID 19266; M01-240149) as an outgroup. The result-
ing distance matrixes were visualised and annotated using SplitsTree4 (version 4.12.8) [22].
Putative recombinations were identified by comparing genomes in term of all NEIS loci
and identifying blocks of differing genes between closely related isolates.
BLAST searches and nucleotide/amino acid sequence alignments
Allelic sequence data were obtained from the PubMLST Neisseria database using the ‘sequence
attribute search’ tool. BLAST searches were performed using the PubMLST BLAST tool.
Nucleotide and amino acid sequence alignments were performed using BioEdit (version
7.0.9.0) [23].
Classification of antibiotic susceptibility
Minimum inhibitory concentration (MIC) breakpoints for antibiotic sensitivities differ
according to publication and by the organisations that define them, including occasional revi-
sions over time. Current EuCAST (v10.0) breakpoints for intravenous administration of peni-
cillin are susceptible�0.06 mg/L and resistant >0.25 mg/L. Studies in animal models,
however, suggest an upper breakpoint of>1 mg/L for resistance [24]. Current EuCAST
(v10.0) breakpoints for ciprofloxacin for use in the prophylaxis of meningococcal disease are
susceptible�0.03 mg/L and resistant >0.03 mg/L.
For the present study, isolates possessing up to five mutations (F504L, A510V, I515V,
H541N and I566V) within the deduced amino acid sequence for a 402 bp fragment (penA) of
the penicillin binding protein 2 gene (PubMLST locus NEIS1753) were predicted to have
reduced susceptibility to penicillin (0.094 to 1 mg/L) in accordance with Taha et al. (2007)
[25]. Isolates with alterations to residues T91 or D95 of the deduced amino acid sequence of
the DNA gyrase gene (gyrA; PubMLST locus NEIS1320) were predicted to be resistant (MIC,
�0.03 mg/L) to ciprofloxacin in accordance with Hong et al., 2013 [7]. Alterations to residues
D86, S87, S88 or E91 of the deduced amino acid sequence of the DNA topoisomerase IV sub-
unit A gene (parC; PubmLST locus NEIS1525) were also noted having previously been associ-
ated with incrementally higher ciprofloxacin MICs when observed in tandem with gyrA
mutations in N. gonorrhoeae [26].
Results
Final genome panel
In addition to the 138 new genomes, the database search yielded 50 genomes including 49
cc4821 genomes and a single ST-unassigned genome (PubMLST ID 85386) that had four
MLST alleles in common with both ST-4821 and ST-8. The latter genome was subsequently
assigned to ST-14840 that, in accordance with the rules by which 7-locus STs are assigned
(https://pubmlst.org/neisseria/info/complexes.shtml), was assigned to the ST-8 complex.
Given the uncertainty regarding the isolate’s true descent it was included in subsequent analy-
ses employing high resolution cgMLST. Collectively, the genomes were from carriage
(n = 121), invasive disease (n = 57), anogenital sites (n = 6) and unspecified (n = 4). The iso-
lates were isolated between 1972 and 2018 in Asia (1972 to 2017, including China, n = 170;
Japan, n = 1); Europe (2011 to 2018, including UK, n = 6; Italy, n = 3; Ireland, n = 2; Greece,
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n = 1; Malta, n = 1; Spain. N = 1; Sweden, n = 1); North America (2007, USA, n = 1); and
South America (2014, Brazil, n = 1) (Table 1).
Population structure
Figs 1 and 2 show the population structure of the genomes highlighting geographical origins,
and serogroup and disease status, respectively. The cc4821 isolates were diverse and formed
four distinct lineages among several relatively diffuse isolates. To maintain a linkage to the pre-
vious studies by Zhu et al. (2015) [5] and Guo et al. (2018) [6] these were designated lineage 1
(corresponding to Zhu/Guo group I/1) and lineages 2a, 2b and 2c (collectively corresponding
to Zhu/Guo group II/2). The positions of isolates used in the earlier studies are shown in S1
Fig. The ST-14840 (cc8) isolate, a Spanish urethral swab isolate from 2018, belonged to lineage
2c confirming it was descended from cc4821 meningococci, rather than those of cc8 to which
it is officially assigned. Each of the four lineages was represented by isolates from multiple Chi-
nese provinces (S2 Fig). With the exception of a single diffuse isolate from China in 1980,
PorA P1.7–2,14 was only observed within a discrete lineage 1 cluster that included the epi-
demic clone isolates as designated by Guo et al. (2018) [6] (S3 Fig). There were 55 sequence
types among the study genomes. Among the predominant sequence types, ST-4821 was dis-
tributed between lineage 1 and several diffuse isolates from 1973 to 1985 (n = 5) and 2009
(n = 1). ST-5664 and ST-9454 were confined to lineage 2a. ST-8491 was confined to MenW
isolates of lineage 2b. ST-3200 and ST-5798 were confined to lineage 2c (S4 Fig).
The geo-temporal composition and disease status of the four lineages was as follows:
Lineage 1. The majority of lineage 1 isolates (n = 51/52, 2004 to 2017) were from China
including 16 carrier isolates belonging to MenC (n = 10; 2005 to 2014), MenB (n = 4; 2009–
2016), and serogroup unknown (n = 2; 2007 and 2009); 34 invasive isolates belonging to MenB
(n = 6, 2008 to 2014) and MenC (n = 28; 2004 to 2016); and a single MenB isolate with disease
status unknown (2005). The remaining isolate was an invasive MenC isolate from Japan
(2017).
Lineage 2a. All lineage 2a isolates (n = 49; 2005 to 2017) were from China and most
(n = 45/49) were MenB. The lineage included 44 carrier isolates (2005 to 2016; MenB, n = 40;
Table 1. Geo-temporal origins of genomes used in the study.
Continent Country Disease state Total
Carrier Invasive Urogenital Unspecified
n Years n Years n years n years
Asia China 112 1972–2017 54 1985–2017 4 1980–2005 170
Japan 1 2017 1
Europe UK 1 2014 5 2011–2018 6
Greece 1 2018 1
Malta 1 2018 1
Italy 2 2016 1 2017 3
Ireland 2 2017 2
Spain 1 2018 1
Sweden 1 2018 1
North America USA 1 2007 1
South America Brazil 1 2014 1
Total 121 57 6 4 188
https://doi.org/10.1371/journal.pone.0243426.t001
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MenC, n = 1; MenX, n = 1; capsule null (cnl), n = 1; and unknown, n = 1), and five invasive
isolates (2011 to 2017; all MenB) (Fig 2). Four of the invasive isolates belonged to a distinct
cluster of relatively closely related isolates.
Lineage 2b. All of the lineage 2b isolates (n = 15; 1972 to 2017) were from China. The
majority (n = 13/15) were carrier isolates including a single MenB (1980), two MenC (1972
and 2007), and ten MenW isolates (2009 to 2017). The two invasive isolates (2002 and 2005)
belonged to MenC and formed a distinct sublineage.
Lineage 2c. The majority (n = 40/57) of the lineage 2c isolates were from China including
29 carrier isolates belonging to MenB (n = 26; 1977 to 2016) and MenC (n = 3; 2016 to 2017),
ten invasive isolates belonging to MenB (n = 9; 2005 to 2013) and MenC (n = 1; 2005) (Fig 2),
and a single MenB isolate (2005) with unknown disease status.
The remaining lineage 2c isolates (n = 17/57) were from nine countries in Europe and
North and South America and formed a distinct cluster within lineage 2c designated the
‘cc4821 lineage 2c RoW (rest of world) cluster’ (Fig 1). These included carrier MenB isolates
from meningococcal carriage studies in the USA (n = 1 isolate; 2007; high school children)
[27]; Brazil (n = 1 isolate; 2014; adolescents) [28]; Italy (n = 2 isolates; 2016; young adults); Ire-
land (n = 2 isolates; 2017; Universities); Greece (n = 1 isolate; 2018; adolescents), Sweden
(n = 1 isolate; 2018; universities) and Malta (n = 1 isolate; 2018; university); and invasive
MenB isolates from Italy (n = 1; 2017) and the UK (n = 1; 2014) (Fig 2). The remaining six
lineage 2c isolates were all from anogenital sites among men who have sex with men (MSM).
These included three UK MenB isolates (2011, 2012 and 2013) that were incidentally isolated
from rectal swabs during routine gonococcal screening [29]. Two of these were from dual
meningococcal/gonococcal coinfections. A further UK MenB rectal swab isolate (2017; age 20
to 30 years) was from a meningococcal/gonococcal coinfected asymptomatic contact of a gon-
ococcal urethritis patient. Another MenB isolate was from a urethral swab from a meningococ-
cal/Chlamydia trachomatis coinfected sex worker with symptoms of urethritis in Spain (2018;
20 to 30 years). The final isolate belonged to MenC and was a urethral swab isolate from a UK
bisexual male practicing protected insertive sex and displaying symptoms of urethritis (2018;
30 to 40 years). Coinfections were ruled out for C. trachomatis, Mycoplasma genitalium and
gonococcus.
Diffuse isolates. The diffuse isolates that were not assigned to particular lineages (n = 15;
1973 to 2011) were all from China and comprised ten carrier isolates including MenB (n = 2;
2009 to 2011) and MenC (n = 8; 1973 to 2008) isolates; three invasive MenB isolates (1985 to
2011); and two MenB isolates with unspecified disease status (1980 to 1985).
Antibiotic resistance determinant genotyping
The different lineages/sublineages contained varying distributions of isolates with fluoroquin-
olone resistance-associated (MICs� 0.03 mg/L) gyrA and parC alleles and penA alleles associ-
ated with reduced penicillin susceptibility (0.094 to 1 mg/L) (Fig 3). Detailed lineage
breakdowns of genotypic antibiotic resistance determinants are depicted in S5 Fig and as
follows:
Lineage 1. All 52 of the lineage 1 isolates possessed mutant (resistance-associated) gyrA
alleles (51x allele 71 and 1x allele 326). Among these, 45 isolates (including 18/20 epidemic
clone isolates) possessed wild type (WT; susceptibility-associated) penA alleles. One of these, a
MenB carrier isolate (2009), also possessed a mutant parC allele (mutation S88P). Three iso-
lates, including an invasive MenB (2014) and MenC (2012) isolate and a carrier MenB isolate
(2016), possessed mutant penA alleles (5x reduced susceptibility-associated alleles). A further
three carrier isolates (including 2/20 epidemic clone) and one invasive isolate did not have full
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length penA sequence data. The single Japanese epidemic clone isolate possessed mutant gyrA
and parC (mutation S87I) alleles and WT penA alleles.
Lineage 2a. Among the lineage 2a carrier isolates, 8/40 MenB isolates (2011 to 2016) and
1/1 MenX isolates (2009) possessed mutant gyrA and penA alleles. Of these, two MenB isolates
(2014 to 2016) also possessed mutant parC alleles (mutation E91K). A further 22/40 MenB iso-
lates (2006 to 2016), and a single cnl (2009) and serogroup-unknown (2016) isolates possessed
mutant gyrA and WT penA alleles. Of these, a single MenB isolate (2013) also possessed a
mutant parC allele (mutation S87I). The remaining 10/40 MenB (2005 to 2014) and 1/1 MenC
(2005) carrier isolates possessed WT gyrA and penA alleles.
Among the five MenB lineage 2a invasive isolates, one (2017) possessed mutant gyrA and
penA alleles, two (2011 to 2013) possessed mutant gyrA alleles and WT penA alleles, and two
(both 2014) possessed WT gyrA and mutant penA alleles.
Lineage 2b. Among the lineage 2b carrier isolates, 1/1 MenB (1980) and 1/2 MenC (1972)
possessed WT gyrA and penA alleles. The other MenC isolate (2007) and 8/10 MenW isolates
(2009 to 2017) possessed mutant gyrA and WT penA alleles. The remaining 2/10 (2014 and
2016) MenW isolates possessed mutant gyrA and penA alleles. The two invasive MenC isolates
(2002 and 2005) possessed WT gyrA and penA alleles.
Lineage 2c. Among the Chinese lineage 2c MenB carrier isolates, 9/26 isolates (1977 to
2011) possessed WT gyrA and penA alleles, 12/26 (2005 to 2016) possessed mutant gyrA and
WT penA alleles, including one isolate with a mutant (S87I) parC allele, 4/26 (2012 to 2014)
possessed WT gyrA and mutant penA alleles, and 1/26 (2013) possessed mutant alleles for both
gyrA and penA. All three Chinese MenC carrier isolates (2016 to 2017) possessed mutant alleles
for both gyrA and penA. Among the Chinese invasive MenB lineage 2c isolates, 4/9 possessed
WT gyrA and penA alleles, 1/9 possessed WT gyrA and mutant penA alleles, 2/9 possessed
mutant gyrA and WT penA alleles, and 2/9 possessed mutant alleles for both gyrA and penA.
The single Chinese invasive MenC isolate possessed mutant gyrA and WT penA alleles. A fur-
ther MenB isolate with unknown disease status possessed WT gyrA and penA alleles.
All 17 lineage 2c RoW isolates possessed WT gyrA alleles and mutant penA alleles.
Diffuse isolates. Among the diffuse carrier isolates 2/2 MenB (2009 and 2011) and 3/8
MenC isolates (1973 to 1978) possessed WT gyrA and penA alleles. A further 4/8 MenC isolates
(2005 to 2008) possessed mutant gyrA and WT penA alleles, while 1/8 MenC isolates (1980)
possessed WT gyrA and incomplete penA alleles.
Among the diffuse invasive isolates, 2/3 MenB isolates (1985 and 2011) possessed WT
alleles for both gyrA and penA. The remaining isolate (2009) possessed mutant gyrA and penA.
The two diffuse isolates with unknown disease status (1980 and 1985) possessed WT gyrA
and penA alleles.
Subcapsular vaccine antigen genes
None of the cc4821/ST-14840 isolates possessed alleles for PorA P1.4 or NadA. Two isolates
had incomplete nhba sequences and one, a UK invasive rectal swab isolate from 2017, had a
frameshifted nhba allele. The remaining 185 isolates possessed alleles for one of 32 intact
NHBA peptides, 22 of which were unique to China, and 27 of which were only, or predomi-
nantly, observed in cc4821 on the PubMLST Neisseria database (accessed 24/06/20). 4CMenB
strain coverage of all but one of the encoded NHBA peptides was unpredictable according to
Fig 1. Population structure of geo-temporally diverse cc4821 isolates highlighting geographic origins. With the exception of a Japanese isolate in
lineage 1, all of the non-Chinese isolates belonged to a discreet ‘Rest of the world’ (Row) cluster. The phylogeny was based on a core genome (1605
loci) comparison. The scale bar represents the number of different loci. UK = United Kingdom.
https://doi.org/10.1371/journal.pone.0243426.g001
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gMATS. The remaining peptide, peptide 10 was predicted by gMATS to be covered and
occurred in a single lineage 2a MenB carrier isolate from 2013 (this isolate possessed an allele
for a non-covered variant 2 fHbp peptide). The majority of isolates 144/188 possessed fHbp
variant 2 or 3 alleles and a further two isolates, a Chinese invasive MenC lineage 1 (non-epi-
demic clone) isolate from 2011 and a Chinese lineage 2c MenC carrier isolate from 2017, pos-
sessed a truncated allele (nonsense mutation) and a complete deletion of fhbp, respectively.
The remaining 42 isolates possessed alleles for one of 13 fHbp variant 1 peptides, eight of
which were only, or predominantly, found in cc4821, and six of which were unique to China
on the PubMLST Neisseria database (accessed 24/06/20). All 13 peptides afforded unpredict-
able 4CMenB strain coverage according to gMATS. Given the general absence of gMATS-pre-
dictable strain coverage, potential strain coverage was estimated based on the most
conservative criteria that any NHBA peptide and any fHbp variant 1 peptide is potentially cov-
ered. Potential antigen-specific strain coverage of cc4821 lineages/sublineages by 4CMenB is
shown in Fig 4. A detailed breakdown of lineage-specific potential 4CMenb strain coverage is
as follows:
Fig 2. Population structure of geo-temporally diverse cc4821 isolates highlighting serogroup and disease status. Group B and C isolates are interspersed
throughout though lineage 1 is predominantly MenC while lineages 2a and 2c are mainly MenB. The MenW isolates formed a discreet cluster in lineage 2b.
cnl = capsule null. NG = non-groupable.
https://doi.org/10.1371/journal.pone.0243426.g002
Fig 3. cc4821 lineage/sublineage distribution of fluoroquinolone resistance-associated gyrA alleles and penA
alleles associated with reduced penicillin susceptibility. gyrA alleles were considered to be associated with
fluoroquinolone resistance (MIC� 0.03 mg/L) if they possessed mutations affecting residues T91 or D95 of the
corresponding peptide. penA alleles were considered to be associated with reduced penicillin susceptibility (0.094 to 1
mg/L) if they encoded the following mutations: F504L, A510V, I515V, H541N and I566V.
https://doi.org/10.1371/journal.pone.0243426.g003
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Lineage 1. At least 50 of the 52 lineage 1 isolates were potentially covered by NHBA
though this was heavily reliant on peptide 503 (n = 43) being covered. The two remaining iso-
lates had incomplete nhba sequences. Interestingly, only 3/16 carrier isolates, including 1/5
epidemic clone carrier isolates (1/4 MenB and 2/10 MenC) were also potentially covered by
fHbp. By contrast, 28/35 of the invasive isolates (3/6 MenB and 25/29 MenC), including 13/15
invasive epidemic clone isolates, were potentially covered by fHbp. One invasive MenC (2011)
isolate possessed a truncated fhbp allele with a nonsense mutation.
Lineage 2a. All 49 lineage 2a isolates were potentially covered by NHBA though this was
heavily reliant on peptides 910 and 688 being covered since these accounted for a half and a
quarter of the isolates, respectively. Among the invasive isolates, 2/5 were also potentially cov-
ered by virtue of one of two different fHbp peptides.
Lineage 2b. All of the lineage 2b isolates were potentially covered by NHBA, though this
was reliant on peptide 697 being covered. Additionally, 1/13 carrier isolates (MenW, 2014)
and the two invasive MenC isolates were potentially covered by virtue of fHbp.
Lineage 2c. All of the 40 Chinese lineage 2c isolates were potentially covered by NHBA
though this was mainly reliant on coverage of peptides 669 (n = 22) and 697 (n = 9). In addi-
tion, 4/25 carrier isolates and 2/10 invasive isolates (MenB, 2011 and MenC, 2005) were poten-
tially covered by fHbp. An fhbp gene was lacking in one MenC carrier isolate (2017) and was
replaced by N. lactamica sequence as previously reported among proposed ST-286 complex
isolates [30].
Fig 4. Genotypic assessment of potential antigen-specific strain coverage of cc4821 lineages/sublineages by
4CMenB. Potential strain coverage was estimated based on the most conservative criteria that any NHBA peptide and
any fHbp variant 1 peptide is potentially covered.
https://doi.org/10.1371/journal.pone.0243426.g004
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Among the lineage 2c RoW isolates, 16/17 were potentially covered by virtue of NHBA, in
particular peptide 669 (n = 15). One MenB isolate from a rectal swab from an invasive disease
patient possessed a frameshifted nhba allele. None of the RoW isolates were covered by fHbp.
Diffuse isolates. Potential 4CMenB coverage of the 15 diffuse isolates was limited to
NHBA, in particular peptide 669 (n = 10).
Distribution of the nitrite reductase (aniA) gene previously associated with
adaptation to the anogenital niche
The acquisition of a working nitrite reductase (aniA) gene has previously been implicated in the
adaptation of meningococci to the anogenital niche [17, 18]. The distribution of aniA alleles
within the cc4821 population structure is shown in S6 Fig. A number of RoW cluster and lineage
2c isolates possessed aniA (NEIS1549) allele 8 that was unique to these and a small number of
other ST-3200 (cc4821) related isolates on the PubMLST Neisseria database (accessed 21/07/20).
A genome comparison of all lineage 2c isolates in terms of all NEIS loci showed that isolates with
aniA allele 8 also possessed a unique nitric oxide reductase (norB; NEIS1548) allele–allele 379.
Most other lineage 2c isolates possessed aniA allele 287 and norB allele 838 in common with
diverse isolates from lineages 2a and 2b. The most commonly observed alleles of the loci immedi-
ately upstream and downstream of aniA and norB did not differ between the two sets of isolates
suggesting a possible recombination event. A nucleotide alignment of aniA, norB and flanking
genes between isolates representative of the putative ancestral (aniA allele 287 and norB allele
838) and putative recombinant (aniA allele 8 and norB allele 379) states identified a potentially
horizontally acquired region of 2022 bp covering 82% of the 5’ end of aniA, 30% of the 5’end of
norB, and the 381 bp intergenic region (S7 Fig). The extent of the change in the respective pep-
tides was relatively modest comprising P23Q, A43T, T45A and the addition of A27, P28, A29
and E30 for AniA (S8A Fig), and I133V, V146A, D206G, T208V for NorB (S8B Fig).
A BLAST search of all genomes (>2Mb) on the PubMLST Neisseria database (n = 30,044;
accessed 1st September 2020) for the putatively acquired 2022 bp sequence identified n = 103
exact, full-length matches, all of which were meningococcal. Thirty eight of these belonged to,
or were closely related to, cc4821, including n = 29 cc4821 lineage 2c isolates from the current
study with aniA allele 8 (n = 28) or aniA allele 733 (n = 1); five cc4821 carriage study isolates
from the UK and Sweden that were not included in the current study (all aniA allele 8); and
four clonal complex-unassigned isolates with<4 MLST alleles in common with ST-4821 (all
aniA allele 8). The latter four isolates each had 4 to 5 loci in common with ST-3200. The cc8
isolate descended of cc4821 (aniA allele 8) was also identified. The remaining BLAST hits were
for MenA ST-4 complex (n = 14; 1915 to 1972) and MenA ST-5 complex (n = 48; 1966 to
2014) isolates and two isolates with incomplete MLST profiles but matching cc5 at six loci.
mtrC analysis among anogenital isolates
The six lineage 2c RoW anogenital isolates possessed mtrC (NEIS1634) allele 93 encoding an
intact peptide.
Discussion
High-resolution phylogenetic analyses have revolutionised our understanding of meningococ-
cal population structures and our ability to identify and track existing and emerging strains
and outbreaks on a global level [31, 32]. Such analyses benefit from the inclusion of geo-tem-
porally diverse isolates to provide the broadest possible view of the corresponding diversity
and to put the constituent strains in context. To this end, our study included all currently avail-
able cc4821 genomes on the PubMLST database (accessed 12/09/19).
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A key finding of our study is the existence of four well defined lineages, versus the two that
were previously identified [5, 6]. Lineage 1 corresponds to the previously identified group I/1
which includes the predominantly MenC epidemic clone with PorA P1.7–2,14 [6]. Lineages
2a, 2b, and 2c, and a number of diffuse isolates/singletons, collectively correspond to the previ-
ously designated group II/2. It was previously noted that group 2 was relatively diverse but the
inclusion of more than five times as many genomes in the present study has helped to resolve
the constituent lineages. The star-like arrangement of the four lineages along with the non-
cc4821 outgroup on the phylogeny suggests that the four lineages have diverged concurrently
from an early common ancestor, however, the relative closeness of lineages 2a, 2b and 2c to
one-another and the benefits of maintaining continuity with previous publications justifies the
chosen lineage designations (2a, 2b and 2c).
Interestingly, with the exception of a lineage 1 epidemic clone MenC case isolate from
Japan in 2017, all of the remaining 17 non-Chinese isolates, from nine countries on three con-
tinents (2007 to 2018), exclusively belonged to a distinct cluster (the RoW cluster) within line-
age 2c. Furthermore, whilst PorA subtype P1.17–6,23 and closely-related subtypes were only
associated with the RoW cluster among our genome panel, they also accounted for 14/27 PorA
subtypes among non-Chinese, non-genomic isolate submissions on the PubMLST Neisseria
database (accessed 13th July 2020; S2 Table). The lineage-specific distribution of several pre-
dominant Sequence Types suggests that the previously reported ‘ST-3200 group’ of invasive
MenB isolates in Taiwan from 1996 to 2002 [33] would also form part of the broader lineage
2c. The global expansion of this particular sublineage may be due to an unknown feature of
the strain making it more transmissible in these populations or may simply be opportune e.g.
due to an international mass gathering [34].
More than a third (6/17) of the lineage 2c RoW cluster isolates were from an anogenital site
among MSM. Although two groups of isolates (a group of three and a group of two) were from
patients attending sexual health services that utilised common microbiology laboratories (at
opposite ends of the UK), the corresponding isolates were distributed over time (2011, 2012
and 2013; and 2017 and 2018, respectively) and within the population structure of the corre-
sponding cluster. Furthermore, the second group also differed from one-another by serogroup.
This, along with the finding of the recent msm carriage study in New York (USA) [14], may be
indicative of a propensity for this cluster to infect the anogenital site as has previously been
observed with ST-11 complex lineage 11.2 strains [15, 16, 18]. One factor in the emergence of
anogenital-associated cc11 strains was the acquisition of an active nitrite reductase (aniA)
gene [15, 18]. Among the cc4821 lineages, only lineage 1 lacked aniA functionality, however,
14/17 lineage 2c RoW isolates, including the anogenital isolates, and 15/40 Chinese lineage 2c
isolates shared a putative ancestral recombination involving partial sequences of the divergent
aniA and norB genes along with the intergenic/promoter regions. Although the corresponding
sequence was exclusively meningococcal on the PubMLST database, its initial origin was likely
in MenA-associated lineages dating back to 1915. It is possible that the newly generated alleles
or the newly acquired intergenic region (containing promoter regions) where many of the
changes occurred, are more efficient than the existing ones. This, however, requires further
investigation. Formal bioinformatic analyses are also required to confirm the origin of the
putatively horizontally acquired sequence. Another possible explanation for this particular
cluster alone being observed in anogenital sites is that Chinese anogenital meningococci from
other lineage 2c clusters or the other cc4821 lineages may simply not be collected, sequenced,
posted or identified as such on PubMLST. Interestingly, lineage 2c also included a rare isolate
lacking an fhbp gene and therefore unable to express fHbp which has also previously been
implicated in adaptation to the anogenital niche [18]. None of the anogenital isolates possessed
LOF mutations in mtrC that have been associated with cervical infection in gonococci and
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urogenitally adapted meningococci from uretheritis outbreaks among heterosexual males [19].
One possible explanation for this is that cc4821 isolates were all isolated from MSM and the
cervix may not have been encountered in recent ancestral isolates.
The absence of the lineage 1 epidemic clone outside of Asia is surprising given that it has
caused most cases of cc4821 disease within China. This may, in part, be due to a lack of corre-
sponding genomes. Canada, for example, has reported IMD due to a P1.7–2,14:ST-4821 isolate
[31, 35] but no genome is currently available. On our phylogeny, with the exception of a single
diffuse isolate from China in 1980, PorA P1.7–2,14 was only observed within the discrete cluster
representing the epidemic clone. This supports PorA P1.7–2,14 as a specific marker for the clone
among cc4821 isolates. In addition, PorA VR1 P1.7–2 alone was a strong marker for the epidemic
clone cluster accounting for 22/23 (96%) isolates. Three of the epidemic clone isolates possessed a
different VR2. In light of this, the lack of the epidemic clone outside of China is further supported
by available PorA data among non-Chinese, non-genomic, cc4821 isolate submissions on the
PubMLST Neisseria database (accessed 13th July 2020). None of the isolates from Europe (France,
n = 2, 2009 and 2011; Spain, n = 2, 2018; Czech Republic, n = 1, 2007; Italy, n = 1, 2020), North
America (USA, n = 14, 2015 to 2019), South America (Brazil, n = 1, 2014), Australasia (Australia,
n = 2, 2012 and 2014; New Zealand, n = 1, 2017) or Asia (Taiwan, n = 2, 2004 and 2005; Vietnam,
n = 1, 2012) possessed the epidemic clone-associated PorA (P1.7–2,14) (S2 Table).
The widespread distribution of fluoroquinolone resistance in cc4821 is well documented
[36]. The present study confirms the distribution of diverse resistance-associated (MICs> 0.03
mg/L) mutant gyrA alleles throughout the four cc4821 lineages and, with the exception of line-
age 1, these were interspersed with isolates possessing susceptibility-associated (MICs�0.03
mg/L) WT alleles. A small number of well distributed isolates also possessed mutant parC alleles
that may further increase fluoroquinolone MICs. Notably, the RoW cluster does not possess a
mutant gyrA, however, it may be susceptible to stable acquisition of fluoroquinolone resistance
given the situation in the broader clonal complex and the gradual emergence of fluoroquinolone
resistance in Western countries [35, 37–39]. Interestingly, all of the RoW isolates possessed a
mutant penA allele associated with reduced penicillin susceptibility (0.094 to 1 mg/L). Although
diverse mutant penA alleles were found among Chinese isolates in each of the four lineages,
they were relatively rare. As the present study constituted a genomic survey, we focussed on
antibiotic resistance/reduced susceptibility determinants commonly associated with cc4821,
rather than phenotypic MICs. Further work may include consideration of other potential resis-
tance determinants such as multidrug efflux systems or beta lactamase, the latter of which has
recently been reported among meningococci in North America and Europe [37, 40, 41].
Potential 4CMenB strain coverage of lineages 2a, 2b and 2c, including the RoW cluster was
heavily reliant on NHBA. As the corresponding peptides are rare among existing MATS data-
sets there is a critical need for MATS analysis of isolates representing each of the main pep-
tides. This may then be used to extend the current list of covered, not covered, and
unpredictable isolates as defined by gMATS [12]. Perhaps reassuringly, more than half of the
lineage 1 isolates, including 85% (28/33) of invasive isolates were also potentially covered by
fHbp. This vaccine may, therefore, be an option if an fHbp lineage 1-possessing MenB strain
should emerge to cause a large outbreak or epidemic. The majority of isolates without a variant
1 fhbp possessed a variant 2 or 3 gene and so the majority of isolates are potentially covered by
Men-fHbp, though this would need confirming with the MeASurE assay [11]. Of concern, two
isolates lacked a functional fhbp and one isolate lacked a function nhba. Such isolates and their
corresponding strains have infrequently been reported before [30, 34, 42] and should be moni-
tored due to the potential for escape of subcapsular vaccines. They should also be considered
when devising new vaccine formulations.
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In conclusion, cc4821 can now be considered in terms of four distinct lineages and the phy-
logeny herein can form a template with which to analyse genomes from prevailing cases. A
small and distinct cluster of lineage 2c is responsible for the majority of cases outside of China
and may have an affinity for anogenital sites. In light of emerging fluoroquinolone and penicil-
lin resistance, uncertain strain coverage by subcapsular vaccines, and the repeated emergence
of MenB cc4821 strains through capsule switching, there is an urgent need to test isolates rep-
resentative of each lineage in the MATS and MeASurE assays.
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